We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Birmingham Hospital Opens New Automated Blood Sciences Laboratory

By LabMedica International staff writers
Posted on 14 Jun 2012
Print article
Image: The new Queen Elizabeth Hospital Birmingham’s laboratory uses state-of-the-art Roche analytical platforms to reduce turnaround times (Photo courtesy of the University Hospitals Birmingham NHS Foundation Trust).
Image: The new Queen Elizabeth Hospital Birmingham’s laboratory uses state-of-the-art Roche analytical platforms to reduce turnaround times (Photo courtesy of the University Hospitals Birmingham NHS Foundation Trust).
A new automated blood sciences laboratory in a Birmingham hospital has an automated track system that simplifies laboratory processes and improves turnaround times.

The University Hospitals Birmingham NHS Foundation Trust has opened an automated blood sciences laboratory at the new Queen Elizabeth Hospital in Birmingham (Birmingham, United Kingdom). Equipped with state-of-the-art Roche (Burgess Hill, United Kingdom) analytical platforms and track system, the new laboratory ensures a very efficient workflow and will reduce turnaround times (TAT) for routine, high throughput work.

The track system consists of two cobas 8000 platforms (one with two cobas c 701 chemistry modules and two cobas e 602 immunoassay modules and the other with one cobas c 701 and two cobas e 602 modules), a modular preanalytics module and a cobas p 501/701 post-analytical unit for automated sample storage and retrieval.

The cobas 8000 modular analyzer series is designed for high workload laboratories and can cover a range of 3 up to 15 million tests per year. With a peak throughput of 8,400 tests per hour and many innovative design elements to allow unrestricted sample flow and intelligent sample routing, the cobas 8000 modular analyzer series significantly improves sample turnaround time and efficiently addresses peak demands. High speed, intelligent sample dynamics, and workflow improvements further enhance productivity and efficiency for high workload laboratories.

“The fully automated track system with pre- and post-analytics has eliminated the need for manual transfer and storage of samples once they are loaded on the system”, explained laboratory manager, Chris Gaskin. “The cobas 8000 platforms are designed for high throughput and the whole Roche solution has helped us to be more lean in our processes and is much more TAT efficient for our high workloads.”

The laboratory also has a standalone cobas p 512 module for automated sample receipt. “In the next few months, we aim to introduce a pneumatic sample delivery system and ward order communications throughout the hospital,” Chris Gaskin concluded. “When a test is requested on the ward, a barcode label will be printed automatically. Then, when samples arrive in the laboratory, they will be loaded directly onto the cobas p 512. The system will register receipt on Laboratory Information Management System (LIMS) and then sort the samples into appropriate racks, depending on their destination. This will eliminate the need for paperwork, allowing the process to be entirely electronic from request to result for the very first time. It will streamline sample reception significantly and will further reduce turnaround times.”

Related Links:
Queen Elizabeth Hospital in Birmingham
Roche

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
25-OH-VD Reagent Kit
New
cTnI/CK-MB/Myo Test
Finecare cTnI/CK-MB/Myo Rapid Quantitative Test

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.